🧠AI AnalysisAnalysis of 1,134 Patients Examines Bridging Therapy Prior to CAR T-Cell Treatment for Lymphoma
A large international retrospective study has evaluated the outcomes of bridging therapy in patients with relapsed or refractory large B-cell lymphoma receiving CD19-dire…